TQB2450 Plus Progestin for Fertility-sparing Treatment in MMRd EC
NCT06914297
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Endometrial Cancer
Interventions
DRUG:
TQB2450 injection + oral progestin
Sponsor
Fudan University